New Zealand Society for Oncology shared a post on LinkedIn:
“We welcome Professor Tony Mok to NZSO 2026. He is a globally recognised leader in lung cancer research and precision oncology and has played a pivotal role in advancing targeted therapies and biomarker-driven treatment approaches.
His work has significantly influenced international clinical practice and continues to shape the future direction of oncology care.
Don’t miss seeing him at NZSO 2026 – register today.”
Other articles about NZSO on OncoDaily.